Opinionated Science Episode 30: Psychedelics: A Trip Through Psilocybin and MDMA Research
On this week’s Opinionated Science, the team takes a look at the growing potential of psychedelic medicine.
Hundreds of new clinical trials, exciting new synthetic psychedelics and a universal acceptance that current mental health treatments are not meeting patients’ needs have pushed the mind-altering potential of psychedelics into the medical mainstream.
In this episode, Technology Networks Senior Science Writer Ruairi J Mackenzie takes a deep dive into four leading psychedelic compounds: psilocybin, MDMA, ketamine and DMT.
Read more from this podcast:
Why Does Ketamine Fight Depression? Finding Answers at BNA 2019
Mirror’s Image: Could a Simple Flip Produce a More Effective Ketamine-Based Antidepressant?
The Neuroscience of Psychedelic Drugs: Your Brain on Psilocybin With Frederick Streeter Barrett
